Journal of International Oncology››2021,Vol. 48››Issue (10): 631-634.doi:10.3760/cma.j.cn371439-20201109-00124
Previous ArticlesNext Articles
Received:2020-11-09Revised:2021-09-15Online:2021-10-08Published:2021-11-24
"
| 组别 | rCBF | Ktrans |
|---|---|---|
| 脑胶质瘤复发组(n=20) | 1.979±0.578 | 1.073±0.551 |
| 放射性脑坏死组(n=20) | 0.630±0.137 | 0.042±0.017 |
| t值 | 10.129 | 8.349 |
| P值 | <0.001 | <0.001 |
"
| 诊断结果 | 常规MRI | 3D-ASL | DCE-MRI | 3D-ASL+DCE-MRI |
|---|---|---|---|---|
| 脑胶质瘤复发 | 14(12) | 25(19) | 13(11) | 21(20) |
| 放射性脑坏死 | 26(15) | 15(12) | 27(18) | 19(17) |
| 合计 | 40(27) | 40(31) | 40(29) | 40(37) |
"
| 检查方法 | 正确例数 | 错误例数 | 合计例数 | 准确率(%) | |
|---|---|---|---|---|---|
| 常规MRI | 27 | 13 | 40 | 67.5 | |
| 3D-ASL | 31 | 9 | 40 | 77.5 | |
| DCE-MRI | 29 | 11 | 40 | 72.5 | |
| 3D-ASL+DCE-MRI | 37 | 3 | 40 | 92.5a | |
| χ2值 | 8.028 | ||||
| P值 | 0.045 | ||||
| [1] | Radin DP, Tsirka SE. Interactions between tumor cells, neurons, and microglia in the glioma microenvironment[J]. Int J Mol Sci, 2020, 21(22):8476. DOI: 10.3390/ijms21228476. doi:10.3390/ijms21228476 |
| [2] | Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary[J]. Acta Neuropathol, 2016, 131(6):803-820. DOI: 10.1007/s00401-016-1545-1. doi:10.1007/s00401-016-1545-1 |
| [3] | Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352(10):987-996. DOI: 10.1056/NEJMoa043330. doi:10.1056/NEJMoa043330 |
| [4] | Alexiou GA, Tsiouris S, Kyritsis AP, et al. Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities[J]. J Neurooncol, 2009, 95(1):1-11. DOI: 10.1007/s11060-009-9897-1. doi:10.1007/s11060-009-9897-1 |
| [5] | Haller S, Zaharchuk G, Thomas DL, et al. Arterial spin labeling perfusion of the brain: emerging clinical applications[J]. Radiology, 2016, 281(2):337-356. DOI: 10.1148/radiol.2016150789. doi:10.1148/radiol.2016150789pmid:27755938 |
| [6] | Hyare H, Thust S, Rees J. Advanced MRI techniques in the monitoring of treatment of gliomas[J]. Curr Treat Options Neurol, 2017, 19(3):11. DOI: 10.1007/s11940-017-0445-6. doi:10.1007/s11940-017-0445-6 |
| [7] | Macdonald DR, Cascino TL, Schold SC Jr, et al. Response criteria for phase Ⅱ studies of supratentorial malignant glioma[J]. J Clin Oncol, 1990, 8(7):1277-1280. DOI: 10.1200/JCO.1990.8.7.1277. doi:10.1200/JCO.1990.8.7.1277pmid:2358840 |
| [8] | Strauss SB, Meng A, Ebani EJ, et al. Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis[J]. Radiol Clin North Am, 2019, 57(6):1199-1216. DOI: 10.1016/j.rcl.2019.07.003. doi:10.1016/j.rcl.2019.07.003 |
| [9] | Zikou A, Sioka C, Alexiou GA, et al. Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas[J]. Contrast Media Mol Imaging, 2018, 2018:6828396. DOI: 10.1155/2018/6828396. doi:10.1155/2018/6828396 |
| [10] | Razek AAKA, El-Serougy L, Abdelsalam M, et al. Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics[J]. Neuroradiology, 2018, 60(2):169-177. DOI: 10.1007/s00234-017-1955-3. doi:10.1007/s00234-017-1955-3 |
| [11] | Zhang J, Liu H, Tong H, et al. Clinical applications of contrast-enhanced perfusion MRI techniques in gliomas: recent advances and current challenges[J]. Contrast Media Mol Imaging, 2017, 2017:7064120. DOI: 10.1155/2017/7064120. doi:10.1155/2017/7064120 |
| [12] | Ye J, Bhagat SK, Li H, et al. Differentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imaging[J]. Exp Ther Med, 2016, 11(6):2432-2436. DOI: 10.3892/etm.2016.3225. doi:10.3892/etm.2016.3225 |
| [13] | Xu Q, Liu Q, Ge H, et al. Tumor recurrence versus treatment effects in glioma: a comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging[J]. Medicine (Baltimore), 2017, 96(50):e9332. DOI: 10.1097/MD.0000000000009332. doi:10.1097/MD.0000000000009332 |
| [14] | Larsen VA, Simonsen HJ, Law I, et al. Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis[J]. Neuroradiology, 2013, 55(3):361-369. DOI: 10.1007/s00234-012-1127-4. doi:10.1007/s00234-012-1127-4 |
| [15] | Shin KE, Ahn KJ, Choi HS, et al. DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma[J]. Clin Radiol, 2014, 69(6):e264-e272. DOI: 10.1016/j.crad.2014.01.016. doi:10.1016/j.crad.2014.01.016 |
| [16] | Bisdas S, Naegele T, Ritz R, et al. Distinguishing recurrent high-grade gliomas from radiation injury[J]. Acad Radiol, 2011, 18(5):575-583. DOI: 10.1016/j.acra.2011.01.018. doi:10.1016/j.acra.2011.01.018 |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
